Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4% Sodium Citrate vs. Heparin as Lock Solution in Hemodialysis
NCT05188339Phase 3Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jul 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trisodium citrate in catheter-related thrombosis (CRT), sponsored by Chang Gung Memorial Hospital. Status: unknown.
02
Drugs
trisodium citrate
03
Conditions
catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on NCT05188339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05188339.